Back to search results

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Abroad (travel likely)RecruitingPHASE4

Conditions

Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA) · Axial Spondyloarthritis (AxSpA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Sint Maartenskliniek Nijmegen, Nijmegen, Gelderland, Netherlands

    Contact: Study coordinator (Dr. N. van Herwaarden) · n.vanherwaarden@maartenskliniek.nl · +31 24 365 94 09

  • Maastricht UMC+, Maastricht, Limburg, Netherlands

    Contact: Study coordinator (Prof dr. A. van Tubergen) · a.van.tubergen@mumc.nl

  • Elisabeth-TweeSteden Ziekenhuis Tilburg, Tilburg, North Brabant, Netherlands

    Contact: Study coordinator (Dr. L Schipper) · l.schipper@etz.nl

  • Medisch Spectrum Twente, Enschede, Overijssel, Netherlands

    Contact: Study coordinator (Prof dr. H. Vonkeman) · h.vonkeman@mst.nl

  • Isala Zwolle, Zwolle, Overijssel, Netherlands

    Contact: Study coordinator (Dr A.E. van der Bijl) · a.e.van.der.bijl@isala.nl

  • Erasmus MC, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Dr. P.H.P. de Jong) · p.h.p.dejong@erasmusmc.nl

  • Maasstad ziekenhuis, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Dr. M. Kok) · kokmr@maasstadziekenhuis.nl
View source on ClinicalTrials.gov(opens in a new tab)